Back to All News & Events

Ketamine and esketamine: key considerations

Go back to Messenger

November Messenger 2020, Prescribing | Posted November 17, 2020

View the clinical toolkit.

Comments for this post are now closed. If you would like to share your feedback on this topic, please email support@cpsa.ca.

Related News

All News & Events

July 21, 2023

Update from TPP Alberta: Forgeries

A breakdown of forgery reports from January-June 2023

July Messenger 2023, Prescribing

July 21, 2023

New electronic fax prescriptions from Connect Care coming July 25

Introducing a more direct and secure way to provide patient prescriptions to community pharmacies

July Messenger 2023, Prescribing

June 8, 2023

A reminder about prescribing high-potency narcotics for the treatment of opioid use disorder

May 11, 2023

Looking to start a PPIP activity? Or earn CME credits? Review your MD Snapshot-Prescribing!

April 20, 2023

Do you prescribe antibiotics? Want to know more about antimicrobial resistance? We want to hear from you!

April 13, 2023

TPP Alberta update: PrescribeIT and Type 1 prescribing requirements

CPSA's 2022 annual report is now available

See highlights from the past year and read accompanying stories online.